@botanicalburr's peptide therapy claims need context

What did @botanicalburr actually say?

The creator made several specific claims about comfrey (Symphytum officinale): that it contains a "growth stimulant" that accelerates healing of bone, tendon, and tissue; that a topical poultice helped a woman with fractured tibia and fibula recover well enough to run within three months; and that warnings about comfrey causing liver damage are overblown, citing a story of a cow that ate only comfrey leaves and thrived. They also described a preparation method involving dried leaves, olive oil, and beeswax for a topical cream.

The liver safety concerns were specifically dismissed using the cow anecdote from a book by Isabelle Shepherd, and by suggesting that sheep "will not eat a plant that will hurt them" as additional evidence of safety.

Does the science back this up?

Topical comfrey has real evidence behind it. The liver safety dismissal does not. These are two very different conversations, and conflating them is where this video gets genuinely dangerous.

On the topical side, allantoin, a compound in comfrey, has documented wound-healing and anti-inflammatory properties. A 2004 randomized controlled trial by Koll et al. in Phytomedicine found that a comfrey root extract ointment significantly reduced pain and swelling in ankle sprains compared to diclofenac gel. A 2012 study by Grube et al. in Phytotherapy Research showed topical comfrey root extract outperformed placebo for acute upper or lower back pain. These are real, peer-reviewed findings.

On liver safety, the evidence is also real and goes the other way. Comfrey contains pyrrolizidine alkaloids (PAs), which are hepatotoxic. The European Medicines Agency and Germany's BfR have both issued warnings against internal use. PA-induced hepatic veno-occlusive disease has been documented in humans after consuming comfrey as tea or supplements (Ridker et al., 1985, Gastroenterology). A cow eating comfrey and appearing healthy is not a clinical trial. It is an anecdote from a self-published herb book.

What did they get wrong (or right)?

They got the topical application largely right. The active compound allantoin does stimulate cell proliferation, which is the scientific basis for calling it a "growth stimulant." The anti-inflammatory and topical analgesic effects are supported by multiple RCTs. Credit where it is due.

The bone fracture story is unverifiable and medically irresponsible as presented. A crushed knee and dual lower-leg fractures require imaging, professional reduction, and often surgical fixation. The video frames prayer and comfrey poultices as the mechanism of recovery, while the doctor's eventual response ("it mustn't have been broken") is used as validation. That is not how fracture management works, and presenting it to 542,000 viewers as a treatment template is a problem.

The safety dismissal is the most serious error. The claim that media warnings are just noise, backed by a cow anecdote and the logic that "sheep won't eat harmful plants," ignores documented human cases of liver failure from internal comfrey use. Sheep and cows metabolize PAs differently than humans. This is not a debatable point.

• Topical comfrey cream: supported by evidence for musculoskeletal pain and minor injuries.
• Internal consumption of comfrey: contraindicated by regulatory bodies in multiple countries.
• Using comfrey poultices instead of surgical fixation for serious fractures: not supported and potentially harmful.

What should you actually know?

Topical comfrey products are available in pharmacies across Europe and have a reasonable safety profile when used on intact skin. If you are looking at a regulated telehealth context, topical allantoin-based preparations are a different category from ingesting the plant or its root.

The pyrrolizidine alkaloid concern is not media hysteria. The FDA issued guidance in 2001 advising against internal use of comfrey. The European Food Safety Authority has classified PAs as genotoxic carcinogens with no safe threshold for intake. Some topical preparations are formulated with PA-reduced extracts specifically to address skin absorption concerns.

The fracture story should not be replicated. If someone you know has a suspected fracture, they need emergency care, imaging, and orthopedic assessment. Comfrey poultices have not been tested in clinical trials for fracture healing in humans, and the mechanism described here mixes anecdote, faith healing, and herbal application in a way that cannot be evaluated or reproduced safely.

The seasonal harvesting advice (leaves in spring and summer, roots in winter) is consistent with traditional use and some phytochemical literature on allantoin distribution, though rigorous modern studies on seasonal variation are limited.